Precision BioSciences Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated May 13, 2020, details the results of the annual meeting of stockholders held by Precision BioSciences, Inc. on that date. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol DTIL.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance.
Material Changes and Voting Results
A total of 42,147,567 shares were present at the meeting, representing approximately 81.97% of the common stock outstanding as of the March 23, 2020 record date. The following proposals were approved:
- Election of Directors (Item 1): Three Class I directors were elected to serve until the 2023 annual meeting.
- Geno Germano: Elected with 35,328,962 votes FOR and 136,066 votes WITHHELD.
- Matthew Kane: Elected with 25,507,655 votes FOR and 9,957,373 votes WITHHELD.
- Raymond Schinazi, Ph.D.: Elected with 28,811,126 votes FOR and 6,653,902 votes WITHHELD.
- Ratification of Auditors (Item 2): The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2020, was approved with 41,047,861 votes FOR, 28,896 votes AGAINST, and 1,070,810 votes ABSTAINED.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the specific reasons for the significant number of votes withheld for director Matthew Kane (9,957,373) compared to his colleagues.
- Confirm the total number of shares outstanding as of the March 23, 2020 record date to validate the 81.97% participation rate.
- Review the Definitive Proxy Statement filed on March 27, 2020, for detailed biographies of the elected directors and the rationale for the auditor appointment.